Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Pulmonary Disease Physician in Kissimmee, FL
NPI: 1538126685Primary Practice Location
Florida Lung Asthma and Sleep Specialists, P.A.
4553 Pleasant Hill Rd, Kissimmee, FL
Primary Employer
AdventHealth Medical Group
adventhealth.com
HQ Phone
Get M.D. Donald's Phone Numberphone_androidMobile
Get M.D. Donald's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
SC State Medical License
FL State Medical License
1992 - 2026
AZ State Medical License
2016 - 2020
SC State Medical License
1988 - 2015
American Board of Internal Medicine
Pulmonary Disease
National Board of Physicians and Surgeons
Internal Medicine
National Board of Physicians and Surgeons
Pulmonary Disease
Palmetto Health Richland
Until 1992
Prisma Health/University of South Carolina SOM Columbia (Columbia)
Residency • Internal Medicine
1987 - 1990
Internship • Internal Medicine
1987 - 1988
Medical University of South Carolina (MUSC)
medicine.musc.edu
Medical School
Until 1987
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 176 | 474 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 165 | 337 |
| 3 | 94010Measurement and graphic recording of total and timed exhaled air capacity | 114 | 199 |
| 4 | 99223Initial hospital inpatient care, typically 70 minutes per day | 95 | 103 |
| 5 | 99291Critical care delivery critically ill or injured patient, first 30-74 minutes | 83 | 211 |
Lead Sponsor: Lung Biotechnology PBC
Intervention / Treatment: DRUG: Placebo, DRUG: Beraprost Sodium 314d Modified Release Tablets
Lead Sponsor: Gilead Sciences
Intervention / Treatment: DRUG: Placebo, DRUG: Ambrisentan
Lead Sponsor: Gilead Sciences
Intervention / Treatment: DRUG: Placebo, DRUG: Ambrisentan, DRUG: Tadalafil, DRUG: Sildenafil
